Skip to main content

Table 6 Comparison between case and control groups as regards the duration of MV and length of stay (days)

From: A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP)

  

Group A

Group B

A/B^

Duration MV

Median (IQR)

19.0

(16.0–26.3)

23.5

(21.3–26.0)

0.037*

Range

13.0–90.0

20.0–38.0

LOS

Median (IQR)

21.5

(16.3–27.0)

25.5

(23.0–28.5)

0.045*

Range

15.0–90.0

20.0–38.0

  1. IQR interquartile range
  2. ^sign is to indicate the use of mann whitney test
  3. *statistical significance of the value according to the mentioned test